Vaccine News and Research

Latest Vaccine News and Research

Study highlights the importance of deeply exploring the immune responses against cancer

Over the past decade, scientists have been exploring vaccination as a way to help fight cancer. These experimental cancer vaccines are designed to stimulate the body's own immune system to destroy a tumor, by injecting fragments of cancer proteins found on the tumor.

16 Sep 2021

Pfizer vaccine induces strong immunity in elderly with prior COVID-19

A new study discusses the vaccination response in elderly who were vaccinated with one dose of the Pfizer vaccine 15 months after contracting COVID-19.

16 Sep 2021

How effective is the Johnson & Johnson COVID-19 vaccine?

A new study demonstrates the real-world efficacy of this vaccine, its stability over time, as well as its efficacy against the SARS-CoV-2 Delta variant.

16 Sep 2021

Reproductive specialist highlights the need to investigate menstrual changes after covid-19 vaccination

Some women say their periods change after getting a covid-19 vaccination. In The BMJ today, Dr Victoria Male, a reproductive specialist at Imperial College London, says a link between menstrual changes after covid-19 vaccination is plausible and should be investigated.

16 Sep 2021

Researchers aim to develop edible plant-based mRNA vaccines

The future of vaccines may look more like eating a salad than getting a shot in the arm. UC Riverside scientists are studying whether they can turn edible plants like lettuce into mRNA vaccine factories.

16 Sep 2021

Single dose of typhoid conjugate vaccine found to be safe and effective in Malawian kids

A new study, published today in the New England Journal of Medicine, finds a single dose of typhoid conjugate vaccine (TCV) – the only typhoid vaccine licensed for children as young as 6 months – is safe and 84 percent effective in protecting against typhoid in Blantyre, Malawi.

16 Sep 2021

Australian study finds enablers and barriers to COVID-19 vaccine uptake

People’s trust in the government’s approval of a safe and effective vaccine against COVID-19 is the biggest driver of vaccine uptake, an Australian study has found.

16 Sep 2021

Live oral SARS-CoV-2 vaccine provides partial protection in Rhesus Macaques

A new study describes the partial protection against respiratory infection with SARS-CoV-2 following gut inoculation with a live attenuated virus.

16 Sep 2021

How Fauci and the NIH got ahead of the FDA and CDC in backing boosters

In January — long before the first jabs of covid-19 vaccine were even available to most Americans — scientists working under Dr. Anthony Fauci at the National Institute of Allergy and Infectious Diseases were already thinking about potential booster shots.

16 Sep 2021

New modeling on efficacy of BioNTech-Pfizer's SARS-CoV-2 vaccine against variants

In order to address these issues, scientists from Xitific LTD and IDEAPharma in the UK proposed a novel approach to the framework of immune correlates, built upon the previous research. The framework formulated by the authors was developed for the mRNA-based vaccinations but could be applied to the other variations.

16 Sep 2021

Therapeutic potential of clinical-grade ACE2 for blocking SARS-CoV-2 variants

According to new research by an international team of scientists, all SARS-CoV-2 variants, including variants of concern (VOC) Alpha, Beta, Gamma, and Delta, exhibit enhanced affinity toward recombinant human soluble ACE2.

16 Sep 2021

Evolved SARS-CoV-2 viruses gain higher infectivity and cause more rapid infection spread

Viruses accumulate mutations as they replicate in infected cells. Repeated replication can lead to viral strains that show attenuated virulence. Such strains may act as vaccines if the attenuated virus can produce immunity without serious disease.

16 Sep 2021

Grants to promote COVID-19 vaccination among people with intellectual and developmental disabilities

Patients with intellectual and developmental disabilities (IDD) are three times more likely to die from COVID-19 than the general population. Their heightened risk is due to a variety of causes: pre-existing health conditions, such as respiratory problems or obesity; increased likelihood of living in group homes, taking shared transportation, and being exposed to people outside their households; and struggles with safety precautions like mask-wearing or social distancing.

16 Sep 2021

Pfizer-BioNTech’s COVID-19 vaccine proves effective against recent SARS-CoV-2 variants

Researchers in the United States and Germany have conducted a study showing that the Pfizer-BioNTech vaccine designed to protect against coronavirus disease 2019 (COVID-19) is effective against recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2).

16 Sep 2021

German chancellor delighted after company visit to KNAUER, calling the company a pearl

German Chancellor Dr. Angela Merkel visited Berlin-based manufacturer of high-tech laboratory instruments KNAUER Wissenschaftliche Geräte GmbH on Friday, Sept. 10, 2021.

From KNAUER Wissenschaftliche Geräte GmbH 16 Sep 2021

Heart inflammation more common among men following mRNA-based COVID-19 vaccination

Researchers in the UK have assessed data from around the world to better understand the frequency and risk factors for myocarditis and pericarditis following immunization with messenger RNA (mRNA)-based vaccines designed to protect against coronavirus disease 2019 (COVID-19).

16 Sep 2021

Vaccine News and Research

Latest Vaccine News and Research

Study highlights the importance of deeply exploring the immune responses against cancer

Pfizer vaccine induces strong immunity in elderly with prior COVID-19

How effective is the Johnson & Johnson COVID-19 vaccine?

Reproductive specialist highlights the need to investigate menstrual changes after covid-19 vaccination

Researchers aim to develop edible plant-based mRNA vaccines

Single dose of typhoid conjugate vaccine found to be safe and effective in Malawian kids

Australian study finds enablers and barriers to COVID-19 vaccine uptake

Live oral SARS-CoV-2 vaccine provides partial protection in Rhesus Macaques

How Fauci and the NIH got ahead of the FDA and CDC in backing boosters

New modeling on efficacy of BioNTech-Pfizer's SARS-CoV-2 vaccine against variants

Therapeutic potential of clinical-grade ACE2 for blocking SARS-CoV-2 variants

Evolved SARS-CoV-2 viruses gain higher infectivity and cause more rapid infection spread

Grants to promote COVID-19 vaccination among people with intellectual and developmental disabilities

Pfizer-BioNTech’s COVID-19 vaccine proves effective against recent SARS-CoV-2 variants

German chancellor delighted after company visit to KNAUER, calling the company a pearl

Heart inflammation more common among men following mRNA-based COVID-19 vaccination

COVID-19 pandemic may have made women think twice about expanding their families, study shows

Saliva test to screen for leading infectious cause of infant hearing loss was feasible and well-received

Study looks at exposure to different SARS-CoV-2 variants and immune response

COVID mRNA vaccines display weakened immune response with age and diminish over time, according to new study

eBook: Advancing infectious disease vaccine development eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in